All posts tagged "FDA"
-
418BiotechCytoDyn (CYDY) Shorts Throttle Up Bashing Ahead of August Super News Cycle
Short attack timed to capitalize on consolidation and thin trading The Oregonian misquotes and twists statements taken out of context SEC case...
-
352BiotechTop Coronavirus Stocks backed by Scientific Evidence
Developing a vaccine to treat COVID-19 is hands down the best way to play the long term coronavirus stocks. Ultimately a vaccine...
-
BiotechA Share Price Surge Speaks to TearLab Corp (OTCMKTS:TEAR) Platform’s Near FDA Approval
An 83% spike in the prices of TearLab Corp (OTCMKTS:TEAR) was the highlight of their week. The company which was trading at...
-
BiotechSANUWAVE Health, Inc. (OTCMKTS:SNWV) Is Just Getting Started
News just hit press that the Food and Drug Administration (FDA) has just approved an asset called the Dermapace System and the...
-
1.6KBiotechBellerophon Therapeutics Inc (NASDAQ:BLPH) Is A Big 2017 Winner For Our Readers
It has been almost eight months since we last covered Bellerophon Therapeutics Inc (NASDAQ:BLPH) as part of this piece back in April....
-
3.1KBiotechDelcath Systems, Inc. (OTCMKTS:DCTH): Here’s Our Take
It’s been a month or so since we last looked at Delcath Systems, Inc. (OTCMKTS:DCTH) as part of this piece. The point...
-
1.6KBiotechImmunomedics Inc (NASDAQ:IMMU) Just Validated Our Bullish Thesis
Back in August, we published this piece on Immunomedics Inc (NASDAQ:IMMU). At the time, the company was ranging between $7-$8.5 a share...
-
3.8KBiotechCelsion Corporation (NASDAQ:CLSN) Just Ran In Line With Our Expectations
It is only been a week or so since we last covered Celsion Corporation (NASDAQ:CLSN) but recent action in the company necessitates...
-
2.4KBiotechInnovus Pharmaceuticals Inc (OTCMKTS:INNV) Finally Just Launched Its Growth Product
Innovus Pharmaceuticals Inc (OTCMKTS:INNV) is a stock that we have looked at on a number of occasions here at Insider Financial and...
-
2.5KBiotechHere’s Where We See Value In Egalet Corp (NASDAQ:EGLT)
Egalet Corp (NASDAQ:EGLT) collapsed back in July this year on the news that the company’s lead development asset – a drug called...